BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Bu B. Yeap, Mark L. Divitini, Jenny E. Gunton, John K. Olynyk, John P. Beilby, Brendan McQuillan, Joseph Hung, Matthew W. Knuiman. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosisClinical Endocrinology 2015; 82(4): 525 doi: 10.1111/cen.12529
2
N. Frank, E. M. Tadros. Insulin dysregulationEquine Veterinary Journal 2014; 46(1): 103 doi: 10.1111/evj.12169
3
Shui-Xian Du, Lin-Lin Lu, Ning Geng, David W. Victor, Li-Zhen Chen, Cong Wang, Hai-Yan Yue, Yong-Ning Xin, Shi-Ying Xuan, Wen-wen Jin. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysisLipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0613-4
4
Maeva Guillaume, Vlad Ratziu. Pharmacological agents for nonalcoholic steatohepatitisHepatology International 2013; 7(S2): 833 doi: 10.1007/s12072-013-9482-8
5
Menezes Nunes. Obesity and Metabolic Syndrome in Children: What’s New?Endocrinology&Metabolism International Journal 2017; 4(3) doi: 10.15406/emij.2017.04.00090
6
Ji Hoon Na, So Won Park, Yunkoo Kang, Hong Koh, Seung Kim. The Clinical Significance of Serum Ferritin in Pediatric Non-Alcoholic Fatty Liver DiseasePediatric Gastroenterology, Hepatology & Nutrition 2014; 17(4): 248 doi: 10.5223/pghn.2014.17.4.248
7
M. Shann Wilson, Erik W. Thompson. Venesection is an effective non-pharmacological treatment for patients with high serum ferritin type 2 diabetesJournal of Clinical and Translational Endocrinology: Case Reports 2017; 3: 1 doi: 10.1016/j.jecr.2016.10.002
8
Nam-Seok Joo, Young-Hwa Choi, Kyung-Jin Yeum, Soo-Jung Park, Beomhee Choi, Young-Sang Kim. Blood Mercury Can Be a Factor of Elevated Serum Ferritin: Analysis of Korea National Health and Nutrition Examination Survey (KNHANES 2008–2012)Biological Trace Element Research 2015; 164(1): 3 doi: 10.1007/s12011-014-0194-2
9
JUN LIAO, XING XIA, GUO-ZUO WANG, YONG-MEI SHI, JIN-WEN GE. Naotaifang extract treatment results in increased ferroportin expression in the hippocampus of rats subjected to cerebral ischemiaMolecular Medicine Reports 2015; 11(6): 4047 doi: 10.3892/mmr.2015.3309
10
Pathik Parikh, Jatin Patel, Meghraj Ingle, Prabha Sawant. Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in IndiaIndian Journal of Gastroenterology 2015; 34(3): 200 doi: 10.1007/s12664-015-0572-5
11
Y. Sumida, E. Niki, Y. Naito, T. Yoshikawa. Involvement of free radicals and oxidative stress in NAFLD/NASHFree Radical Research 2013; 47(11): 869 doi: 10.3109/10715762.2013.837577
12
Homayoon BASHIRI, Arezoo BOZORGOMID, Vahid SHOJAEIMOTLAGH. Efficacy of Hijamat (wet cupping therapy) in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trialTURKISH JOURNAL OF MEDICAL SCIENCES 2020; 44(2): 354 doi: 10.3906/sag-1907-82
13
Luca Valenti, Raffaela Rametta, Paola Dongiovanni, Benedetta M. Motta, Elena Canavesi, Serena Pelusi, Edoardo A. Pulixi, Anna L. Fracanzani, Silvia Fargion, Giovanni Targher. The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver DiseasePLoS ONE 2012; 7(11): e48804 doi: 10.1371/journal.pone.0048804
14
George BB Goh, Danny Issa, Rocio Lopez, Srinivasan Dasarathy, Jaividhya Dasarathy, Ruth Sargent, Carol Hawkins, Rish K Pai, Lisa Yerian, Amer Khiyami, Mangesh R Pagadala, Achuthan Sourianarayanane, Naim Alkhouri, Arthur J McCullough. The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver diseaseJournal of Gastroenterology and Hepatology 2016; 31(5): 995 doi: 10.1111/jgh.13235
15
Erika Wichro, Tanja Macheiner, Jasmin Schmid, Barbara Kavsek, Karine Sargsyan. The Wide and Complex Field of NAFLD Biomarker Research: TrendsISRN Hepatology 2014; 2014: 1 doi: 10.1155/2014/846923
16
Holly N. Wilkinson, Sophie E. Upson, Kayleigh L. Banyard, Robert Knight, Kimberly A. Mace, Matthew J. Hardman. Reduced Iron in Diabetic Wounds: An Oxidative Stress-Dependent Role for STEAP3 in Extracellular Matrix Deposition and RemodelingJournal of Investigative Dermatology 2019; 139(11): 2368 doi: 10.1016/j.jid.2019.05.014
17
Münevver Demir, Sonja Lang, Hans-Michael Steffen. Nonalcoholic fatty liver disease - current status and future directionsJournal of Digestive Diseases 2015; 16(10): 541 doi: 10.1111/1751-2980.12291
18
Raffaelle K Barros, Helma Pinchemel Cotrim, Carla H Daltro, Yanaihara A Oliveira. Hyperferritinemia in patients with nonalcoholic fatty liver diseaseRevista da Associação Médica Brasileira 2017; 63(3): 284 doi: 10.1590/1806-9282.63.03.284
19
Alessandro Federico, Claudio Zulli, Ilario de Sio, Anna Del Prete, Marcello Dallio, Mario Masarone, Carmela Loguercio. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2014; 20(45): 16841-16857 doi: 10.3748/wjg.v20.i45.16841
20
Philipp Bernhardt, Wolfgang Kratzer, Julian Schmidberger, Tilmann Graeter, Beate Gruener. Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosisBMC Research Notes 2018; 11(1) doi: 10.1186/s13104-018-3212-1